Abstract:Adipose tissues are classified into white adipose tissue (WAT) and brown adipose tissue (BAT). WAT is responsible for energy storage, and malfunction is associated with obesity. BAT, on the contrary, consumes fat to generate heat through uncoupling mitochondrial respiration and is important in body weight control. Vascular endothelial growth factor (VEGF)-A is the founding member of the VEGF family and has been found highly expressed in adipose tissue. A genetic mouse model of an inducible VEGF (VEGF-A) repres… Show more
“…Notably, overexpression of Vegf in adipose tissues of mice increases BAT mass, stimulates beiging and promotes a healthy metabolic profile 93,94 . Vegf inhibition has also been shown to reduce metabolic disease in mice, although this effect was in the context of obese WAT that was already dysfunctional 94,95 . Further studies will be needed to elucidate the mechanism(s) by which VEGF manipulates the fate of adipose tissue under different metabolic states.…”
Section: Sympathetic Nerve Control Of Brown and Beige Fatmentioning
Adipose tissue, best known for its role in fat storage, can also suppress weight gain and metabolic disease through the action of specialized, heat-producing adipocytes. Brown adipocytes are located in dedicated depots and express constitutively high levels of thermogenic genes, whereas inducible 'brown-like' adipocytes, also known as beige cells, develop in white fat in response to various activators. The activities of brown and beige fat cells reduce metabolic disease, including obesity, in mice and correlate with leanness in humans. Many genes and pathways that regulate brown and beige adipocyte biology have now been identified, providing a variety of promising therapeutic targets for metabolic disease.npg
“…Notably, overexpression of Vegf in adipose tissues of mice increases BAT mass, stimulates beiging and promotes a healthy metabolic profile 93,94 . Vegf inhibition has also been shown to reduce metabolic disease in mice, although this effect was in the context of obese WAT that was already dysfunctional 94,95 . Further studies will be needed to elucidate the mechanism(s) by which VEGF manipulates the fate of adipose tissue under different metabolic states.…”
Section: Sympathetic Nerve Control Of Brown and Beige Fatmentioning
Adipose tissue, best known for its role in fat storage, can also suppress weight gain and metabolic disease through the action of specialized, heat-producing adipocytes. Brown adipocytes are located in dedicated depots and express constitutively high levels of thermogenic genes, whereas inducible 'brown-like' adipocytes, also known as beige cells, develop in white fat in response to various activators. The activities of brown and beige fat cells reduce metabolic disease, including obesity, in mice and correlate with leanness in humans. Many genes and pathways that regulate brown and beige adipocyte biology have now been identified, providing a variety of promising therapeutic targets for metabolic disease.npg
“…Serum levels of VEGF-A are raised during obesity (9)(10)(11) and rapidly decrease following bariatric surgery (10), suggesting that elevated VEGF is deleterious. In support of this Lu et al (12) showed that VEGF knockdown suppressed obesity and promoted "browning" of white adipose tissue (WAT). In contrast, reports using adipose-specific VEGF transgenic or knockout mice suggest that increased expression of VEGF is beneficial during obesity (12)(13)(14)(15).…”
mentioning
confidence: 82%
“…In support of this Lu et al (12) showed that VEGF knockdown suppressed obesity and promoted "browning" of white adipose tissue (WAT). In contrast, reports using adipose-specific VEGF transgenic or knockout mice suggest that increased expression of VEGF is beneficial during obesity (12)(13)(14)(15). This is further complicated by contradictory reports depending on the model system; Sun et al (13) found that antibody neutralization of VEGF impaired metabolic homeostasis in a dietary model of obesity but improved glucose tolerance in a genetic (ob/ob) model.…”
The vascular endothelial growth factor (VEGF) family of cytokines are important regulators of angiogenesis that have emerged as important targets for the treatment of obesity. While serum VEGF levels rise during obesity, recent studies using genetic models provide conflicting evidence as to whether VEGF prevents or accelerates metabolic dysfunction during obesity. In the current study, we sought to identify the effects of VEGF-A neutralization on parameters of glucose metabolism and insulin action in a dietary mouse model of obesity. Within only 72 h of administration of the VEGF-A–neutralizing monoclonal antibody B.20-4.1, we observed almost complete reversal of high-fat diet–induced insulin resistance principally due to improved insulin sensitivity in the liver and in adipose tissue. These effects were independent of changes in whole-body adiposity or insulin signaling. These findings show an important and unexpected role for VEGF in liver insulin resistance, opening up a potentially novel therapeutic avenue for obesity-related metabolic disease.
“…The specificity of amplification was confirmed by melting curve analysis and gel electrophoresis. All results were normalized to the levels of 18S ribosomal (r)RNA, and relative quantification was calculated using relative quantification (ΔΔCq) values for each biological replicate (16,17). Values are expressed as the mean ± standard error of the mean (SEM; triplicate samples and three repeats).…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.